An Exhibitor Theater
held during the
40th ASHP Midyear Clinical Meeting
Monday, December 5, 2005
11:15 am – 1:45 pm
Room N261
Las Vegas Convention Center
Las Vegas, Nevada

 


Planned and conducted by
ASHP Advantage. Supported
by an educational grant from Adolor Corporation and GlaxoSmithKline.

Learning Objectives

At the conclusion of this program, participants should be able to:

  • Describe the pathophysiology of post-operative ileus (POI).
  • List two supportive options for treating POI and the evidence that supports
    each option.
  • Discuss the efficacy and toxicity of three classes of medications that have been utilized for postoperative ileus.
  • Distinguish between the mechanisms of action of peripherally active opioid receptor antagonists from currently available drug therapies for the
    treatment of POI.
  • List two factors that will may be considered when reviewing the mu-receptor antagonists for formulary addition.